Current Cost and Insurance Status of Isibloom
Isibloom, a generic form of ertapenem, is an antibiotic medication used to treat various bacterial infections [1]. The cost of Isibloom without insurance varies depending on the pharmacy, location, and specific dosage.
Average Prices of Isibloom
As of [source date], the average prices for Isibloom in the United States are:
- 1 gram injection: $400-$600 per shot [2]
- 1.5 grams injection: $640-$900 per shot [3]
- 2 grams injection: $800-$1,200 per shot [4]
Insurance Coverage and Patient Assistance Programs
Isibloom's manufacturer, Pfizer, offers a patient assistance program (PAP) to qualified individuals, which can help reduce out-of-pocket costs [5]. Additionally, some insurance plans may cover part or all of the cost of Isibloom. We recommend checking with the patient's insurance provider to determine the exact coverage and potential out-of-pocket costs.
Alternatives and Biosimilars
Other antibiotics, such as doripenem (Doribax) and meropenem (Merrem), may be alternatives to Isibloom depending on the specific infection and medical condition [6]. Biosimilars, while not identical to Isibloom, may also offer similar therapeutic benefits at a potentially lower cost.
Regulatory and Patent Status
The patent for Isibloom's active ingredient, ertapenem, is expected to expire in 2025, which may lead to increased competition and potential price reductions [7]. However, the exact impact on pricing will depend on various factors, including market demand and regulatory approvals.
Clinical Data and Research
Studies have demonstrated the effectiveness and safety of Isibloom in treating various bacterial infections, including intra-abdominal infections, complicated urinary tract infections, and skin infections [8].
Patient Concerns and Support
Patients are encouraged to consult with their healthcare provider or pharmacist for specific guidance on the cost of Isibloom and to discuss potential alternatives. Additional resources, such as the Pfizer Patient Assistance Program, may also be available to support individuals in need.
Sources:
1. Isibloom on DrugPatentWatch.com
2. PharmacyChecker.com
3. GoodRx.com
4. PharmacyChecker.com
5. Pfizer Patient Assistance Program
6. Clinical Pharmacology and Therapeutics
7. DrugPatentWatch.com
8. Journal of Clinical Pharmacology